title: Response to: Cryoglobulinemic vasculitis in the era of direct-acting antiviral drug.
authors.affiliation: Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, Paris, France.|Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France.|INSERM, UMR_S 959, Paris, France.|CNRS, FRE3632, Paris, France.|Department of Internal Medicine and Clinical Immunology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
authors.forename: David
authors.initials: D
authors.lastname: Saadoun
authors.affiliation: Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, Paris, France.|Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France.|INSERM, UMR_S 959, Paris, France.|CNRS, FRE3632, Paris, France.|Department of Internal Medicine and Clinical Immunology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
authors.forename: Patrice
authors.initials: P
authors.lastname: Cacoub
mesh_terms: D000998:Antiviral Agents; D003449:Cryoglobulinemia; D016174:Hepacivirus; D006526:Hepatitis C; D006801:Humans; D014657:Vasculitis
chemical_list: D000998:Antiviral Agents
keywords: Analgesics; Arthritis; Chemokines